# PAVmed Inc. (PAVM)

- Sector: Healthcare · Industry: Medical Devices
- SEC CIK: 0001624326 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001624326))
- Full page: https://inspectstocks.com/stocks/pavm
- Data as of: price 2026-09-29; newest filing used 2026-08-13; latest fiscal period ended 2026-06-30

## Grade

**D-** on the growth-and-cash rubric, 2 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | failed | $112K | $800K |
| Revenue growing recently | passed | $112K | $71K |
| Free cash flow positive | failed | -$7.8M |  |
| Free cash flow growing overall | passed | -$7.8M | -$65.9M |
| Free cash flow growing recently | failed | -$7.8M | -$5.2M |

Business quality (the + / − mark): 1 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -10,794.6% |  |
| Healthy profit margin | failed | -10,794.6% |  |
| Strong operating margin | failed | -23,842.9% |  |
| Good return on equity | failed | -35.6% |  |
| Debt under control | passed | 0.07 |  |
| Turns sales into cash | failed | -6,948.2% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $112K |
| Net income, trailing twelve months | -$12.1M |
| Free cash flow, trailing twelve months | -$7.8M |
| Net margin | -10,794.6% |
| Operating margin | -23,842.9% |
| Return on equity | -35.6% |
| Debt to equity | 0.07 |
| Diluted EPS, trailing twelve months | $14.90 |
| Share price | $3.82 |
| Market value | $15M |
| Price / earnings | 0.3x |
| Price / sales | 134.1x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/pavm)
- [Financial statements](https://inspectstocks.com/stocks/pavm/financials)
- [Competitors](https://inspectstocks.com/stocks/pavm/peers)
- [Earnings](https://inspectstocks.com/stocks/pavm/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.